Solventum Corporation
$69.51
▲
0.78%
2026-04-22 10:12:13
www.solventum.com
NYQ: SOLV
Explore Solventum Corporation stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$12.08 B
Current Price
$69.51
52W High / Low
$88.2 / $62.38
Stock P/E
7.83
Book Value
$29.1
Dividend Yield
—
ROCE
5.66%
ROE
38.86%
Face Value
—
EPS
$8.88
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
20,584
Beta
0.77
Debt / Equity
103.94
Current Ratio
1.23
Quick Ratio
0.89
Forward P/E
9.34
Price / Sales
1.37
Enterprise Value
$15.78 B
EV / EBITDA
13.54
EV / Revenue
1.9
Rating
Buy
Target Price
$86.08
EPS Forecast (FY)
—
Pros
- Healthy return on equity.
- Short-term liquidity looks comfortable.
- Net margin remains healthy.
- Valuation is not stretched on P/E basis.
Cons
- Capital efficiency is modest.
- Operating margin is thin.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ResMed Inc. | $224.49 | 22.19 | $32.69 B | 1.06% | 23.58% | 25.68% | $293.81 / $202 | $43.39 |
| 2. | KORU Medical Systems, Inc. | $4.26 | — | $200.78 M | — | -14.86% | -15.58% | $6.61 / $2.08 | $0.37 |
| 3. | AngioDynamics, Inc. | $10.79 | — | $449.55 M | — | -11.8% | -17.47% | $13.99 / $8.36 | $4.16 |
| 4. | Azenta, Inc. | $26.4 | — | $1.22 B | — | -1.19% | 1.53% | $41.73 / $19.87 | $37.26 |
| 5. | Avantor, Inc. | $8.5 | — | $5.76 B | — | 5.22% | -9.2% | $16.17 / $7.26 | $8.24 |
| 6. | Teleflex Incorporated | $131.95 | — | $5.84 B | 1.03% | 4.14% | 1.58% | $138.93 / $100.18 | $70.7 |
| 7. | Kestra Medical Technologies, Ltd. | $23.31 | — | $1.33 B | — | -41.27% | -92.65% | $30 / $13.25 | $4.94 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 2 B | 2.1 B | 2.16 B | 2.07 B | 2.08 B | — |
| Operating Profit | 93 M | 172 M | 214 M | 152 M | 136 M | — |
| Net Profit | 63 M | 1.27 B | 90 M | 137 M | 31 M | — |
| EPS in Rs | 0.36 | 7.3 | 0.52 | 0.79 | 0.18 | 0.7 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 8.32 B | 8.25 B | 8.2 B | 8.13 B |
| Operating Profit | 632 M | 1.04 B | 1.64 B | 1.69 B |
| Net Profit | 1.56 B | 479 M | 1.35 B | 1.34 B |
| EPS in Rs | 8.97 | 2.76 | 7.76 | 7.74 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 14.29 B | 14.46 B | 13.94 B | 13.59 B |
| Total Liabilities | 9.24 B | 11.5 B | 2.28 B | 1.85 B |
| Equity | 5.05 B | 2.96 B | 11.67 B | 11.74 B |
| Current Assets | 3.86 B | 3.25 B | 2.52 B | 2.23 B |
| Current Liabilities | 3.14 B | 2.7 B | 1.73 B | 1.31 B |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 369 M | 1.19 B | 1.92 B | 1.68 B |
| Investing CF | 2.8 B | -380 M | -230 M | -253 M |
| Financing CF | -3.06 B | -240 M | -1.55 B | -1.46 B |
| Free CF | -10 M | 805 M | 1.62 B | 1.43 B |
| Capex | -379 M | -380 M | -290 M | -251 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 0.7% | 0.82% | — | — |
| Earnings Growth % | -64.41% | 0.22% | — | — |
| Profit Margin % | 5.8% | 16.42% | 16.52% | — |
| Operating Margin % | 12.55% | 19.96% | 20.82% | — |
| Gross Margin % | 55.65% | 57.25% | 57.75% | — |
| EBITDA Margin % | 18.5% | 27.18% | 27.92% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.